Royce & Associates’s Harrow HROW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57M Buy
154,587
+114,874
+289% +$4.27M 0.05% 460
2026
Q1
$1.4M Sell
39,713
-470,033
-92% -$20.7M 0.01% 626
2025
Q4
$25M Sell
509,746
-23,267
-4% -$977K 0.25% 111
2025
Q3
$25.7M Sell
533,013
-20,680
-4% -$779K 0.26% 117
2025
Q2
$16.9M Buy
553,693
+226,597
+69% +$6.09M 0.17% 179
2025
Q1
$8.7M Buy
327,096
+35,006
+12% +$1.05M 0.09% 317
2024
Q4
$9.8M Sell
292,090
-68,230
-19% -$3.02M 0.09% 328
2024
Q3
$16.2M Sell
360,320
-179,580
-33% -$6.07M 0.15% 192
2024
Q2
$11.3M Buy
539,900
+225,000
+71% +$3.36M 0.11% 274
2024
Q1
$4.17M Buy
314,900
+20,000
+7% +$213K 0.04% 537
2023
Q4
$3.3M Buy
294,900
+4,900
+2% +$58K 0.03% 573
2023
Q3
$4.17M Buy
290,000
+107,000
+58% +$1.87M 0.04% 514
2023
Q2
$3.48M Buy
+183,000
New +$4.03M 0.03% 574

Other funds holding HROW

Royce & Associates's HROW Position: Q2 2026 in Review

Royce & Associates increased its Harrow (HROW) stake by 289% in Q2 2026, buying an estimated $4.27M and bringing the position to 154,587 shares worth $6.57M. The position accounts for 0.05% of the portfolio, ranked #460.

Royce & Associates first reported a position in HROW in Q2 2023 and has held it in 13 quarters since. The position peaked at $25.7M in Q3 2025. 223 funds tracked by Wall St. Rank hold HROW as of Q2 2026.

  • Royce & Associates held 154,587 shares of Harrow worth $6.57M as of Q2 2026.
  • Royce & Associates bought 114,874 Harrow shares in Q2 2026, an estimated $4.27M.
  • Harrow made up 0.05% of Royce & Associates's portfolio in Q2 2026, its #460 holding.
  • Royce & Associates first reported a position in Harrow in Q2 2023 and has held it in 13 quarters since.
  • Royce & Associates's Harrow position peaked at $25.7M in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Harrow as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.